Results 141 to 150 of about 1,669 (180)

Human Monocytic Ehrlichiosis in Children

Pediatrics, 1997
Background. Much of what is known about human monocytic ehrlichiosis (HME) is based upon studies with adult patients.Purpose. To review our experience with HME to better understand the epidemiology, clinical manifestations, and outcome of this disease in children.Methods.
Gordon E Schütze, Richard F Jacobs, Jacobs Richard F   +2 more
exaly   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Human Monocytic Ehrlichiosis and Human Granulocytic Anaplasmosis in the United States, 2001-2002

Annals of the New York Academy of Sciences, 2006
Abstract:  The epidemiologic features are described of cases of human monocytic ehrlichiosis and human granulocytic anaplasmosis in the United States.
Robert C Holman, John W Krebs, Jennifer H Mcquiston   +2 more
exaly   +3 more sources

Human Monocytic Ehrlichiosis

, 2015
Heinz Mehlhorn
core   +3 more sources

Human Monocytic Ehrlichiosis

JAMA, 2004
A 56-year-old man with a history of Wegener granulomatosis presented with 6 days of sinus congestion, fever, malaise, myalgias, episcleritis, and a morbilliform rash. An exacerbation of Wegener granulomatosis was the principal concern because of the frequency of flares in that disease.
John H, Stone, Kerry, Dierberg, Ghazaleh, Aram, J Stephen, Dumler   +3 more
openaire   +2 more sources

Human Monocytic Ehrlichiosis in Children

Pediatric Infectious Disease Journal, 2007
Human monocytic ehrlichiosis (HME) is a tick-borne illness caused by Ehrlichia chaffeensis. Data about disease in children have been largely derived from case reports or small case series.A retrospective review of all medical and laboratory records from 6 sites located in the "tick belt" of the Southeastern United States was carried out.
Gordon E, Schutze, Steven C, Buckingham, Gary S, Marshall, Charles R, Woods, Mary Anne, Jackson, Lori E, Patterson, Richard F, Jacobs   +6 more
openaire   +2 more sources

Human monocytic ehrlichiosis in a renal transplant patient

Scandinavian Journal of Infectious Diseases, 2006
Human ehrlichiosis is an emerging pathogen in immunocompromised patients, potentially leading to increased morbidity compared to immunocompetent patients. A high index of suspicion is imperative and early treatment with doxycycline can be life-saving.
Casey, Cotant, Jason F, Okulicz, Barton, Brezina, Daniel J, Riley, Nicholas G, Conger   +4 more
openaire   +2 more sources

HUMAN MONOCYTIC EHRLICHIOSIS: AN EMERGING PATHOGEN IN TRANSPLANTATION

Transplantation, 2001
The spectrum of disease caused by Ehrlichia spp. ranges from asymptomatic to fatal. Awareness and early diagnosis of the infection is paramount because appropriate therapy leads to rapid defervescence and cure. If left untreated, particularly in immunosuppressed patients, ehrlichioses may result in multi-system organ failure and death.We report the ...
H P, Tan, J S, Dumler, W R, Maley, A S, Klein, J F, Burdick, F, Fred Poordad, P J, Thuluvath, J S, Markowitz   +7 more
openaire   +2 more sources

Fatal human monocytic ehrlichiosis: a case study

Forensic Science, Medicine, and Pathology, 2011
Human ehrlichiosis is the term for a collection of tick-borne diseases caused primarily by obligate intracellular bacteria of the Ehrlichia species. Ehrlichiosis is characterized by a mild to severe illness, with approximately 3-5% of cases proving fatal despite receiving appropriate care.
Joseph J, Pavelites, Joseph A, Prahlow
openaire   +2 more sources